Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
We compared CSF and serum levels of iron, copper, manganese, and zinc, measured by atomic absorption spectrophotometry, in 26 patients patients with Alzheimer's disease (AD) without major clinical signs of undernutrition, and 28 matched controls. CSF zinc levels were significantly decreased in AD patients as compared with controls (p < 0.05). The serum levels of zinc, and the CSF and serum levels of iron, copper, and manganese, did not differ significantly between AD-patient and control groups. These values were not correlated with age, age at onset, duration of the disease, and scores of the MiniMental State Examination in the AD group. Weight and body mass index were significantly lower in AD patients than in controls. Because serum zinc levels were normal, the possibility that low CSF zinc levels were due to a deficiency of dietary intake seems unlikely. However, it is possible that they might be related to the interaction of beta-amyloid and/or amyloid precursor protein with zinc, that could result in a depletion of zinc levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Molina et al. (91) examined 26 AD and 28 control subjects and found a significant decrease in cerebrospinal fluid zinc levels in AD patients.”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [91]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · cited 1×
“Evaluation of each patient included: anamnesis and neurological examination, Mini-Mental State Examination ( Folstein et al., 1975 ), Hachinski Ischemic Score (Hachinski et al., 1975), Hamilton’s Rating Scale for depression (Hamilton, 1969), and laboratory tests (blood cell count, urinalysis, blood routine biochemistr…”
MethodHamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · cited 1×
“B) Criteria for “probable AD” according to the NINCDS-ADRDA Work Group criteria ( McKahnn et al., 1984 ).”
Method. Cerebral blood flow in dementia.
Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., McAllister, V. L., Marshall, J., Russell, R. W. R., & Symon, L. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510088009 · Cited by 3,186 · cited 2×
“Evaluation of each patient included: anamnesis and neurological examination, Mini-Mental State Examination (Folstein et al., 1975), Hachinski Ischemic Score (Hachinski et al., 1975), Hamilton’s Rating Scale for depression (Hamilton, 1969), and laboratory tests (blood cell count, urinalysis, blood routine biochemistry…”
MethodDEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E., LEES, A. J., JENNER, P., & MARSDEN, C. D. (1991) · Brain · doi:10.1093/brain/114.4.1953 · Cited by 1,043
Oxygen radicals and the nervous system
Halliwell, B., & Gutteridge, J. M. C. (1985) · Trends in Neurosciences · doi:10.1016/0166-2236(85)90010-4 · Cited by 819 · cited 1×
“Iron (Halliwell and Gutteridge, 1988), copper (Halliwell and Gutteridge, 1985), and manganese (Donaldson et al., 1992) act as prooxidant agents.”
BackgroundThe Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I)
Multhaup, G., Schlicksupp, A., Hesse, L., Beher, D., Ruppert, T., Masters, C. L., & Beyreuther, K. (1996) · Science · doi:10.1126/science.271.5254.1406 · Cited by 678
Deibel, M. A., Ehmann, W. D., & Markesbery, W. R. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00203-1 · Cited by 540 · cited 3×
“There have been described decreased copper concentrations in the hippocampus and amygdala (Deibel et al., 1996).”
BackgroundGood, P. F., Perl, D. P., Bierer, L. M., & Schmeidler, J. (1992) · Annals of Neurology · doi:10.1002/ana.410310310 · Cited by 476 · cited 1×
“Iron levels have been described to be increased in the hippocampus (Morris et al., 1994; Deibel et al., 1996), amygdala (Deibel et al., 1996) frontal cortex (Kala et al., 1996; Loeffler et al., 1995), globus pallidus (Loeffler et al., 1995) and cerebellum (Kala et al., 1996), and it has been described accumulation of…”
BackgroundA Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra
Saggu, H., Cooksey, J., Dexter, D., Wells, F. R., Lees, A., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb11759.x · Cited by 454 · cited 2×
“constituents of the cytosolic Cu/Zn- and the mitochondrial Mn-superoxide dismutases, respectively, which could protect against oxidative processes (Marttila et al., 1988; Saggu et al., 1989).”
BackgroundBrain iron and ferritin in Parkinson’s and Alzheimer’s diseases
Jellinger, K., Paulus, W., Grundke-Iqbal, I., Riederer, P., & Youdim, M. B. H. (1990) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02252926 · Cited by 445 · cited 1×
“The transferrin C2 subtype has been found increased in the AD brain (Van Rensburg et al., 1995), and ferritine immunoreactivity has been found increased in senile plaques and neurofibrillary tangles (Connor et al., 1993; Jellinger et al., 1990 ).”
BackgroundEpidemiology of Dementia and Alzheimer's Disease
Hendrie, H. C. (1998) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199821001-00002 · Cited by 412
Saura, J., Luque, J. M., Cesura, A. M., Prada, M. D., Chan-Palay, V., Huber, G., Löffler, J., & Richards, J. G. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90311-5 · Cited by 382 · cited 1×
“Ceruloplasmin concentrations have been described to be increased in the frontal, temporal and parietal cortices ( Saura et al., 1994 ), hippocampus, entorrhinal cortex and putamen (Loeffler et al., 1996), although Connor et al. (1993) reported decreased ceruloplasmin in the superior temporal gyrus.”
BackgroundAre reactive oxygen species involved in Alzheimer's disease?
Benzi, G. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00066-n · Cited by 365 · cited 2×
“role of oxidative stress in the pathogenesis of AD (reviewed by Benzi and Moretti, 1995; Jimenez-Jimenez et al., 1996).”
BackgroundTransferrin and Iron in Normal, Alzheimer's Disease, and Parkinson's Disease Brain Regions
Loeffler, D. A., Connor, J. R., Juneau, P. L., Snyder, B. S., Kanaley, L., DeMaggio, A. J., Nguyen, H., Brickman, C. M., & LeWitt, P. A. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020710.x · Cited by 334 · cited 1×
“, 1996) frontal cortex (Kala et al., 1996; Loeffler et al., 1995), globus pallidus (Loeffler et al.”
BackgroundEffect of Zinc on Cells and Biomembranes
Chuapil, M. (1976) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31862-4 · Cited by 256 · cited 1×
“anhydrase (Constantinidis, 1990, 1991), and has a stabilizing influence on membranes (Chvapil, 1976).”
BackgroundMeret, S., & Henkin, R. I. (1971) · Clinical Chemistry · doi:10.1093/clinchem/17.5.369 · Cited by 253
Lipid Peroxidation and Free Radical Scavengers in Alzheimer’s Disease
Jeandel, C., Nicolas, M. B., Dubois, F., Nabet-Belleville, F., Penin, F., & Cuny, G. (1989) · Gerontology · doi:10.1159/000213037 · Cited by 250 · cited 3×
“Other authors reported decreased serum zinc (Gronek et al., 1989; Jeandel et al., 1989 ), and normal serum copper levels (Jeandel et al., 1989).”
BackgroundResultInfluentialOxygen toxicity protecting enzymes in Parkinson's disease
Marttila, R. J., Lorentz, H., & Rinne, U. K. (1988) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(88)90108-6 · Cited by 249
FREE-RADICAL OXIDATION AND ANTIOXIDANTS
Dormandy, T. L. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91148-0 · Cited by 236 · cited 1×
“Paradoxically, copper is also essential for the antioxidant function of the protein ceruloplasmin ( Dormandy, 1978 ), and copper and manganese are constituents of the cytosolic Cu/Zn- and the mitochondrial Mn-superoxide dismutases, respectively, which could protect against oxidative processes (Marttila et al., 1988; S…”
BackgroundIncreased regional brain concentrations of ceruloplasmin in neurodegenerative disorders
Loeffler, D. A., LeWitt, P. A., Juneau, P. L., Sima, A. A. F., Nguyen, H.-U., DeMaggio, A. J., Brickman, C. M., Brewer, G. J., Dick, R. D., Troyer, M. D., et al. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00782-2 · Cited by 236 · cited 1×
“, 1994), hippocampus, entorrhinal cortex and putamen (Loeffler et al., 1996), although Connor et al.”
BackgroundMetals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease.
Basun, H., Forssell, L. G., Wetterberg, L., & Winblad, B. G. (1991) · PubMed · Cited by 228
Sulkava, R., Haltia, M., Paetau, A., Wikstrom, J., & Palo, J. (1983) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.46.1.9 · Cited by 207 · cited 1×
“No patient had “definite AD” because the inclusion in this group requires brain biopsy, but the accuracy of the diagnosis of AD based upon clinical and laboratory evaluation is estimated around 80% (Sulkava et al., 1983).”
BackgroundPlasma Concentrations of Vitamins A and E and Carotenoids in Alzheimer's Disease
ZAMAN, Z., ROCHE, S., FIELDEN, P., FROST, P. G., NIRIELLA, D. C., & CAYLEY, A. C. D. (1992) · Age and Ageing · doi:10.1093/ageing/21.2.91 · Cited by 202 · cited 1×
“We also found decreased serum retinol concentrations, as it was previously reported (Jeandel et al., 1989; Zaman et al., 1992).”
ResultTrace element imbalances in isolated subcellular fractions of Alzheimer's disease brains
Wenstrup, D., Ehman, W. D., & Markesbery, W. R. (1990) · Brain Research · doi:10.1016/0006-8993(90)91804-p · Cited by 189 · cited 2×
“found decreased zinc concentrations in Alzheimer’s disease brain (Corrigan et al., 1993; Cuajungco and Lees, 1997; Ward and Mason, 1987; Wenstrup et al., 1990).”
BackgroundZinc and Alzheimer's disease: is there a direct link?
Cuajungco, M. P., & Lees, G. J. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00002-7 · Cited by 170 · cited 4×
“protein with zinc, that could result in a depletion of zinc levels (Cuajungco and Lees, 1997).”
BackgroundInfluentialSerum levels of the iron binding protein p97 are elevated in Alzheimer′s disease
Kennard, M. L., Feldman, H., Yamada, T., & Jefferies, W. A. (1996) · Nature Medicine · doi:10.1038/nm1196-1230 · Cited by 169 · cited 1×
“The serum levels of iron binding protein p97 has been found increased ( Kennard et al., 1996 ), and the plasma levels of the zinc carrier peptide thymulin decreased”
BackgroundManganese neurotoxicity: a model for free radical mediated neurodegeneration?
Donaldson, J., McGregor, D., & LaBella, F. (1982) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y82-208 · Cited by 162
The Role of Iron in Beta Amyloid Toxicity
Schubert, D., & Chevion, M. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2678 · Cited by 159
A New Method for Serum Iron and Total Iron-Binding Capacity by Atomic Absorption Spectrophotometry
Olson, A. D., & Hamlin, W. B. (1969) · Clinical Chemistry · doi:10.1093/clinchem/15.6.438 · Cited by 131 · cited 1×
“Copper and zinc were determined in serum by AAS using a Perkin-Elmer 2380 spectrophotometer after the proper dilution (1 : 4). The iron analysis was carried out by AAS using a Perkin-Elmer 2380 spectrophotometer according to Olson and Hamlin (1969) .”
MethodA POSSIBLE ROLE OF ZINC IN THE PATHOLOGY OF DEMENTIA
Burnet, F. M. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90062-3 · Cited by 131
Hippocampal tin, aluminum and zinc in Alzheimer's disease
Corrigan, F. M., Reynolds, G. P., & Ward, N. (1993) · BioMetals · doi:10.1007/bf00205853 · Cited by 129
Hershey, C. O., Hershey, L. A., Varnes, A., Vibhakar, S. D., Lavin, P., & Strain, W. H. (1983) · Neurology · doi:10.1212/wnl.33.10.1350 · Cited by 121
Griffiths, P. D., & Crossman, A. R. (1993) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107298 · Cited by 113 · cited 1×
“On the other hand, Griffiths and Crossman (1993) reported decreased iron levels in the medial segment of globus pallidus.”
BackgroundCeruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease
Connor, J. R., Tucker, P., Johnson, M. J., & Snyder, B. S. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90805-u · Cited by 102 · cited 1×
“noreactivity has been found increased in senile plaques and neurofibrillary tangles (Connor et al., 1993; Jellinger et al., 1990).”
BackgroundZinc, copper and magnesium concentration in serum and CSF of patients with neurological disorders
Kapaki, E., Segditsa, J., & Papageorgiou, C. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb03803.x · Cited by 92 · cited 2×
“Kapaki et al. (1989) described decreased CSF zinc, normal CSF copper, and normal serum zinc and copper levels, in 5 AD patients compared with 28 non agematched controls.”
BackgroundResultCeruoplasmin Is Increased in Cerebrospinal Fluid in Alzheimerʼs Disease but Not Parkinsonʼs Disease
Loeffler, D. A., DeMaggio, A. J., Juneau, P. L., Brickman, C. M., Mashour, G. A., Finkelman, J. H., Pomara, N., & LeWitt, P. A. (1994) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199408030-00005 · Cited by 78 · cited 2×
“tions have been reported to be increased (Loeffler et al., 1994).”
BackgroundIron in the brain: implications for Parkinson's and Alzheimer's diseases.
Youdim, M. B. H. (1988) · PubMed · Cited by 72
Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus.
Morris, C. M., Kerwin, J. M., & Ja, E. (1994) · PubMed · Cited by 61
Kuiper, M. A., Mulder, C., van Kamp, G. J., Scheltens, P., & Wolters, E. C. (1994) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260965 · Cited by 58 · cited 1×
“CSF levels of transferrin have been reported to be normal (Loeffler et al., 1994) and CSF ferritine levels increased in patients with AD ( Kuiper et al., 1994 ).”
BackgroundTrace elements in the human central nervous system studied with neutron activation analysis
Plantin, L. O., Lying-Tunell, U., & Kristensson, K. (1987) · Biological Trace Element Research · doi:10.1007/bf02796622 · Cited by 56
Serum zinc, senile plaques, and neurofibrillary tangles
Tully, C. L., Snowdon, D. A., & Markesbery, W. R. (1995) · Neuroreport · doi:10.1097/00001756-199511000-00002 · Cited by 44
Transferrin C2 and Alzheimer's disease: Another piece of the puzzle found?
van Rensburg, S. J., Carstens, M. E., Potocnik, F. C. V., van der Spuy, G. D., van der Walt, B. J., & Taljaard, J. J. F. (1995) · Medical Hypotheses · doi:10.1016/0306-9877(95)90178-7 · Cited by 35
[Alzheimer's disease and the zinc theory].
Constantinidis, J. (1990) · PubMed · Cited by 31
Brain Samples from Alzheimer's Patients Have Elevated Levels of Loosely Bound Iron
Kala, S. V., Hasinoff, B. B., & Richardson, J. S. (1996) · International Journal of Neuroscience · doi:10.3109/00207459608986717 · Cited by 28 · cited 2×
“Iron levels have been described to be increased in the hippocampus (Morris et al., 1994; Deibel et al., 1996), amygdala (Deibel et al., 1996) frontal cortex ( Kala et al., 1996; Loeffler et al., 1995), globus pallidus (Loeffler et al., 1995) and cerebellum (Kala et al., 1996), and it has been described accumulation of…”
BackgroundConstantinidis, J. (1991) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199100510-00004 · Cited by 26 · cited 2×
“Zinc has antioxidant activity (Dexter et al., 1991), is a constituent of the cytosolic Cu/Zn-superoxide dismutase (Marttila et al., 1988; Saggu et al., 1989) and of enzymes implicated in DNA metabolism, glutamate-dehydrogenase, lactic-dehydrogenase and carbonicanhydrase ( Constantinidis, 1990, 1991 ), and has a stabil…”
BackgroundCSF zinc in Alzheimer's type dementia
Sahu, R. N., Pandey, R. S., Subhash, M. N., Arya, B. Y. T., Padmashree, T. S., & Srinivas, K. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90190-4 · Cited by 22
Licastro, F., Davis, L. J., Mocchegiani, E., & Fabris, N. (1996) · Biological Trace Element Research · doi:10.1007/bf02790147 · Cited by 16
Molecular genetics of Alzheimer's disease.
Goate, A. (1997) · PubMed · Cited by 16
[Serum zinc levels in various mental disorders].
Gronek, I., & Kolomaznik, M. (1989) · PubMed · Cited by 7
Cited by
Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease
Prasad, A. S. (2013) · Advances in Nutrition · doi:10.3945/an.112.003210 · Cited by 919
Metal dyshomeostasis and oxidative stress in Alzheimer’s disease
Greenough, M. A., Camakaris, J., & Bush, A. I. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.08.014 · Cited by 436
Metals and amyloid‐β in Alzheimer's disease
Maynard, C. J., Bush, A. I., Masters, C. L., Cappai, R., & Li, Q. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00434.x · Cited by 353
“…increased serum and CSF Cu levels (Basun et al. 1991; Gonzalez et al. 1999; Squitti et al. 2002) and decreased serum Fe and Zn (Loeffler et al. 1994; Molina et al. 1998), suggesting a redistribution of metals between the brain and the fluids responsible for supplying and clearing excreted metals…”
BackgroundOxidative stress in Alzheimer's disease
Chauhan, V., & Chauhan, A. (2006) · Pathophysiology · doi:10.1016/j.pathophys.2006.05.004 · Cited by 342
Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: A meta-analysis
Schrag, M., Mueller, C., Zabel, M., Crofton, A., Kirsch, W. M., Ghribi, O., Squitti, R., & Perry, G. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.07.005 · Cited by 336
“8% (Agarwal et al., 2008; Arnal et al., 2010; Baum et al., 2010; Brewer et al., 2010; Cristalli et al., 2012; Gerhardsson et al., 2008; Gonzalez et al., 1999; Jeandel et al., 1989; Kapaki et al., 1989; Molaschi et al., 1996; Molina et al., 1998; Mueller et al., 2012; Sedighi et al., 2006; Sevim et al., 2007; Shore et…”
Metadata
- Authors
- Molina, J. A., Jiménez-Jiménez, F. J., Aguilar, M. V., Meseguer, I., Mateos-Vega, C. J., González-Muñoz, M. J., de Bustos, F., Porta, J., Ortí-Pareja, M., Zurdo, M., Barrios, E., & Martínez-Para, M. C.
- Affiliations
- Hospital Universitario 12 De Octubre (ES)
- Hospital Universitario Príncipe de Asturias (ES)
- Universidad de Alcalá (ES)
- Venue
- Journal of Neural Transmission
- Published
- 1998
- Volume
- 105
- Issue
- 4
- Pages
- 479
- ISSN
- 0300-9564 (ISSN-L)
- OpenAlex
- W2007947235
- Cited by
- 167
- References
- 50
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 5 · 2021: 5 · 2020: 5 · 2019: 3 · 2018: 5 · 2017: 14 · 2016: 6 · 2015: 6 · 2014: 5 · 2013: 15 · 2012: 12
- FWCI
- 0.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, cerebrospinal fluid, transition metals, zinc, iron, copper, manganese, serum metal levels, metal deficiency, amyloid-beta, amyloid precursor protein, body mass index, malnutrition
- MeSH terms
- Aged, Alzheimer Disease, Blood Proteins, Copper, Female, Humans, Iron, Male, Manganese, Nutritional Status, Reference Values, Spectrophotometry, Atomic, Trace Elements, Vitamin A, Zinc, Metals, Heavy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.